High-resolution entry and exit surface dosimetry in a 1.5 T MR-linac

被引:5
|
作者
Patterson, E. [1 ]
Stokes, P. [4 ]
Cutajar, D. [1 ]
Rosenfeld, A. [1 ,2 ]
Baines, J. [4 ,5 ]
Metcalfe, P. [1 ,2 ,3 ]
Powers, M. [4 ,5 ]
机构
[1] Univ Wollongong, Ctr Med & Radiat Phys, Wollongong, NSW, Australia
[2] Univ Wollongong, Illawarra Hlth Med Res Inst, Wollongong, NSW, Australia
[3] Ingham Inst Appl Med Res, Liverpool, NSW, Australia
[4] Townsville Hosp, Townsville Canc Ctr, Hlth Serv, Townsville, Qld, Australia
[5] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia
关键词
MR-linac; Elekta Unity; MOSFET; Skin dose; Surface dosimetry; Monte Carlo; MV RADIOTHERAPY ACCELERATOR; SKIN DOSE MEASUREMENT; IN-VIVO DOSIMETRY; MAGNETIC-FIELD; MOSKIN DETECTOR; TLD EXTRAPOLATION; SCANNER; BEAM; ORIENTATION; ENTRANCE;
D O I
10.1007/s13246-023-01251-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The magnetic field of a transverse MR-linac alters electron trajectories as the photon beam transits through materials, causing lower doses at flat entry surfaces and increased doses at flat beam-exiting surfaces. This study investigated the response of a MOSFET detector, known as the MOSkin (TM), for high-resolution surface and near-surface percentage depth dose measurements on an Elekta Unity. Simulations with Geant4 and the Monaco treatment planning system (TPS), and EBT-3 film measurements, were also performed for comparison. Measured MOSkin (TM) entry surface doses, relative to D-max, were (9.9 +/- 0.2)%, (10.1 +/- 0.3)%, (11.3 +/- 0.6)%, (12.9 +/- 1.0)%, and (13.4 +/- 1.0)% for 1 x 1 cm(2), 3 x 3 cm(2), 5 x 5 cm(2), 10 x 10 cm(2), and 22 x 22 cm(2) fields, respectively. For the investigated fields, the maximum percent differences of Geant4, TPS, and film doses extrapolated and interpolated to a depth suitable for skin dose assessment at the beam entry, relative to MOSkin (TM) measurements at an equivalent depth were 1.0%, 2.8%, and 14.3%, respectively, and at a WED of 199.67 mm at the beam exit, 3.2%, 3.7% and 5.7%, respectively. The largest measured increase in exit dose, due to the electron return effect, was 15.4% for the 10 x 10 cm(2) field size using the MOSkin (TM) and 17.9% for the 22 x 22 cm(2) field size, using Geant4 calculations. The results presented in the study validate the suitability of the MOSkin (TM) detector for transverse MR-linac surface dosimetry.
引用
收藏
页码:787 / 800
页数:14
相关论文
共 50 条
  • [31] Microstructure Analysis and Dosimetry with EBT Film in MR-Linac
    Yadav, P.
    Corbella, C.
    Keidar, M.
    Das, I.
    MEDICAL PHYSICS, 2022, 49 (06) : E758 - E759
  • [32] Dose Calculation Accuracy of Beam Models in RadCalc for a 1.5 T MR-Linac
    Sung, Jiwon
    Choi, Yeonho
    Kim, Jun Won
    Lee, Ho
    CANCERS, 2024, 16 (03)
  • [33] Performance characterization of the Blue Physics scintillator in the 1.5T MR-linac
    Oolbekkink, S.
    van Asselen, B.
    Woodings, S.
    Wolthaus, J.
    de Vries, W.
    van Appeldoorn, A.
    Feijoo, M.
    van den Dobbelsteen, M.
    Raaymakers, B.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S470 - S471
  • [34] Quantifying uncertainties associated with reference dosimetry in an MR-Linac
    Iakovenko, Viktor
    Keller, Brian
    Malkov, Victor N. N.
    Sahgal, Arjun
    Sarfehnia, Arman
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2023, 24 (11):
  • [35] Evaluation of the Geometric Distortion in Clinical MR Sequences for a 1.5T MR-Linac System
    Aima, M.
    Slagowski, J. M.
    Ding, Y.
    Vedam, S.
    Yang, J.
    Hwang, K.
    Szklaruk, J.
    Choi, S.
    Fuller, C. D.
    Chung, C.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E684 - E685
  • [36] Pre-treatment portal dosimetry for the MR-Linac
    Xirau, I. Torres
    Olaciregui-Ruiz, I.
    Mans, A.
    van der Heide, U. A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S249 - S249
  • [37] Acute toxicity of MR-guided radiotherapy for prostate cancer at the 1.5 T MR-linac
    Moller, P. K.
    Gornitzka, J.
    Bernchou, U.
    Dysager, L.
    Bertelsen, A. S.
    Nyborg, C. J.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S401 - S402
  • [38] Patient Experience of MR-guided Radiotherapy using a 1.5T MR-Linac
    Westerhoff, J.
    van Otterloo, S. de Mol
    Leer, T.
    Daamen, L.
    Rutgers, R.
    Meijers, L.
    Intven, M.
    Verkooijen, H.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S109 - S110
  • [39] Validation of a diode-based phantom for high temporal and spatial measurements in a 1.5 T MR-linac
    Oolbekkink, Stijn
    Wolthaus, Jochem W. H.
    van Asselen, Bram
    van den Dobbelsteen, Madelon
    Raaymakers, Bas W.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2025, 26 (02):
  • [40] Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac
    Wang, Jihong
    Salzillo, Travis
    Jiang, Yongying
    Mackeyev, Yuri
    Fuller, Clifton David
    Chung, Caroline
    Choi, Seungtaek
    Hughes, Neil
    Ding, Yao
    Yang, Jinzhong
    Vedam, Sastry
    Krishnan, Sunil
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 55 - 64